Does TACROLIMUS Cause Posterior reversible encephalopathy syndrome? 1,118 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,118 reports of Posterior reversible encephalopathy syndrome have been filed in association with TACROLIMUS (Tacrolimus). This represents 1.2% of all adverse event reports for TACROLIMUS.
1,118
Reports of Posterior reversible encephalopathy syndrome with TACROLIMUS
1.2%
of all TACROLIMUS reports
145
Deaths
589
Hospitalizations
How Dangerous Is Posterior reversible encephalopathy syndrome From TACROLIMUS?
Of the 1,118 reports, 145 (13.0%) resulted in death, 589 (52.7%) required hospitalization, and 202 (18.1%) were considered life-threatening.
Is Posterior reversible encephalopathy syndrome Listed in the Official Label?
Yes, Posterior reversible encephalopathy syndrome is listed as a known adverse reaction in the official FDA drug label for TACROLIMUS.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Posterior reversible encephalopathy syndrome?
METHOTREXATE (951)
CYCLOSPORINE (898)
VINCRISTINE (685)
CYCLOPHOSPHAMIDE (658)
MYCOPHENOLATE MOFETIL (621)
PREDNISONE (614)
DEXAMETHASONE (586)
METHYLPREDNISOLONE (579)
PREDNISOLONE (473)
RITUXIMAB (459)
Which TACROLIMUS Alternatives Have Lower Posterior reversible encephalopathy syndrome Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB